Guillermo de Velasco

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

April, 2025

Guillermo de Velasco

Dec 9, 2024, 19:14 | Insight

Efficacy of Treatments After Lenvatinib in Patients with Advanced Renal Cell Carcinoma

Toni Choueiri shared a post on X: "Efficacy of Treatments After Lenvatinib in Patients with…

Aug 25, 2024, 13:02 | Insight

Toni Choueiri: Results from LITESPARK-005 are out

Toni Choueiri shared a post on X about a recent paper titled "Belzutifan versus Everolimus…

Aug 24, 2024, 05:36 | Insight

Roberto Iacovelli: Proud of being part of this achievement in renal cancer

Roberto Iacovelli shared on X: “I am so proud of being part of this achievement…

Aug 23, 2024, 11:39 | Opinion

Toni K. Choueiri: LITESPARK-005 is out

Toni K. Choueiri shared on LinkedIn: “LITESPARK-005 is out in NEJM Group —First in class…

Jul 3, 2024, 00:35 | Blog

Yüksel Ürün: An honor and a pleasure to take part in GUARD Symposium 2024

Yüksel Ürün shared a post by Guillermo de Velasco, Clinical Research and Attending Medical Oncologist…

All: 5 Posts: 1 - 100

'

Senate President Passes Away After Brave Battle with Cancer: Dominick J. Ruggerio

'

Where to Study to Become ASCO President: 2025 Institutional Rankings

'

Yelak Biru: UK grants first approval for Blenrep in multiple myeloma

'

Eric Abidal and Liver Cancer: How He Returned to Football After Overcoming Illness

'

Dr. Don Dizon and Dr. Nathan Pennell Reflect on the Evolution of the ASCO Educational Book

Special Coverage

Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023